ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Net income 2016–2025
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$1.6MFY2025 · since FY2016: -$81.7M → -$1.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.6M | +99.7% |
| FY2024 | -$599.5M | -192.0% |
| FY2023 | -$205.3M | -16.6% |
| FY2022 | -$176.1M | -25.0% |
| FY2021 | -$140.8M | -66.6% |
| FY2020 | -$84.6M | -224.4% |
| FY2019 | $68.0M | +224.8% |
| FY2018 | -$54.5M | -58.4% |
| FY2017 | -$34.4M | +57.9% |
| FY2016 | -$81.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ARWR financial trends
ARWR RevenueARWR Net marginARWR Gross profitARWR Gross marginARWR Operating incomeARWR Operating marginARWR Operating cash flowARWR Free cash flowARWR Capital expendituresARWR Return on equityARWR Stock buybacksARWR Dividends paidARWR Total assetsARWR Total liabilitiesARWR Shareholders’ equityARWR overview →